COLUMBIA, Mo.–(BUSINESS WIRE)–Sinclair Research, one of the nation’s leading providers of nonclinical services, has named Dr. Alric López, DVM, PhD, DACVP, as principal anatomic veterinary pathologist. In this newly created role, Dr. López will have overall responsibility for driving the growth of Sinclair’s dedicated pathology, necropsy and histology services to support a growing toxicology and efficacy model service offering as well as fostering positive relationships with current sponsors and new customers.
Dr. López became a board-certified pathologist by the American College of Veterinary Pathologists (ACVP) in 2003 and has extensive experience authoring comprehensive GLP-compliant pathology narrative reports of microscopic, gross, and clinical pathology findings for Investigational New Drug (IND) purposes.
“Alric is an experienced pathologist who is well-known in the industry,” said Guy Bouchard, DVM, president of Sinclair Research Center. “He is an expert in evaluating and reporting GLP toxicologic pathology data for reports routinely submitted to regulatory agencies and proficient with Xybion’s Pristima® Suite™, our preferred preclinical software platform. Alric will be an asset to our clients, our consultants and their GLP reports.”
Alric joins Sinclair Research from Tox Path, LLC where he leveraged more than 15 years of experience in toxicologic pathology in GLP environments for clients around the world. Prior to consulting, he served as senior pathologist at HistoTox Labs, Envigo and Covance Laboratories, gaining experience in acute toxicology, subchronic/chronic studies, carcinogenicity studies, safety pharmacology, discovery pharmacology, lung and liver fibrosis, DSS and other models of gastrointestinal inflammation, glomerulonephritis, endocrine pancreas, immunotoxicology and immunohistochemistry. Alric is active in industry pathology associations including the ACVP and the Society of Toxicologic Pathology (STP).
About Sinclair Research
Sinclair Research Center, a preclinical contract research organization (CRO), offers animal efficacy models, IND-enabling and specialty toxicology services and compliant research capabilities to support biopharmaceutical, animal health and medical device development programs. Sinclair is experienced in all research models and the undisputed experts in miniature swine. With more than 50 years’ experience, Sinclair has emerged as a leader in diabetes, dermal and animal health research services with streamlined quality systems supporting both VICH and GLP compliant studies and SEND reporting with no backlog.